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Excessive sun tanning can result in addictive behavior. In this issue of Cell, Fell et al. utilize a com-
bination of behavioral pharmacology and transgenic mice to demonstrate that chronic UV light
exposure recruits p53 signaling in keratinocytes, subsequently increasing b-endorphin signaling
at opioid receptors, and produces an endogenous opioid-dependent state.Excessive sun tanning remains a poorly
understood and underappreciated socie-
tal problem, despite heightened aware-
ness of skin cancer risk. Clinical reports
suggest that individuals may develop sun
tanning addictions (Nolan and Feldman,
2009). Endogenous opioid receptors and
their cognate ligands, including b-endor-
phin, are implicated in mediating the rein-
forcing effects of natural reward anddrugs
of abuse (LeMerrer et al., 2009).Opioid re-
ceptor blockade decreases tanners’ pref-
erences for UV beds over sham beds and
produces a withdrawal state in some tan-
ning addicts (Kaur et al., 2006), suggesting
that endogenous opioids mediate tanning
addiction. To date, it has been difficult to
determine whether UV light produces
changes in endogenous opioid systems
that promote tanning addiction in humans.
In this issue of Cell, Fell et al. (2014)
provide innovative evidence that chronic
UV exposure leads to an endogenous
opioid-dependent state (Figure 1). Mice
exposed to chronic UV light displayed
elevated plasma b-endorphin levels and
an increase in opioid receptor signaling
indicated by an increase in mechanical
and thermal analgesia and tail rigidity
(an index of tail opioid receptor signaling)
that is blocked by the opioid receptor
antagonist naloxone. An opioidwithdrawal
syndrome was precipitated by naloxone
in UV exposed mice as assessed by so-
matic signs of opiate withdrawal and
conditioned place aversion. Systemic
b-endorphin administration mimicking
UV-light-induced elevations in peripheral
b-endorphin producedaplace preference,
suggesting that b-endorphin signaling is
rewarding. The authors established a link1500 Cell 157, June 19, 2014 ª2014 Elsevierbetween UV-light-evoked increases in
b-endorphin levels and increases in
analgesia and naloxone-precipitated
opioid withdrawal utilizing b-endorphin
knockout mice. Genetic ablation of p53 in
keratinocytes abolished chronic UV light-
evoked elevations in plasma b-endorphin,
increases in mechanical nociceptive
thresholds, and naloxone-precipitated
withdrawal. This study provides crucial ev-
idence that chronic UV light increases
b-endorphin signaling via opioid recep-
tors, a process initiated by keratinocyte
p53 signaling, to produce endogenous
opioid dependence (Figure 1).
UV light exposure led to tolerance and
withdrawal, key features of opioid depen-
dence. This study brings up exciting future
directions, as physical dependence does
not necessarily imply addiction. Addiction
is also associated with preoccupation
with obtaining/taking drugs, uncontrolled
drug use despite negative consequences,
and recurrent cycles of abstinence and
relapse. It is not clear whether UV-treated
animals were ‘‘addicted’’ to endogenous
opioids or motivated to seek UV light. It is
worthwhile to determine (1) whether ani-
mals work for UV light exposure like drugs
of abuse, (2) whether UV light seeking
would persist despite negative con-
sequences, and (3) whether animals would
relapse after abstinence. Dissection of
effects of UV light exposure on behavior
may elucidate whether UV light produces
both an addictive and dependent state
similar to abused opioids.
Fell and colleagues elegantly demon-
strated a key role for b-endorphin and
opioid receptors in mediating UV light-
induceddependence;however, theneuro-Inc.biological mechanism remains to be eluci-
dated (Fell et al., 2014). It is unclear
whether b-endorphin is producing depen-
dence by acting on peripheral opioid
receptors to change flow of peripheral in-
formation into central circuits or whether
circulating b-endorphin is reaching opioid
receptors in central circuits. Work evalu-
ating the site/s of action of b-endorphin—
and the opioid receptor (mu- versus
delta-opioid receptors) on which it acts—
would point to neural circuits and mecha-
nismsmediating UV effects on motivation.
One shared feature of drugs of abuse is
that they elevate dopamine levels in
reward-related brain regions (Di Chiara
and Imperato, 1988). Opioids act in these
circuits to produce their reinforcing ef-
fects. Furthermore, drugs of abuse,
including opioids, strengthen excitatory
synapses (Saal et al., 2003) and block
strengthening of inhibitory synapses (Nu-
gent et al., 2007) onto midbrain dopamine
neurons. This is a mechanism by which
opioids can produce long-lasting shifts in
excitation/inhibition balance in dopamine
neurons, promoting long-lasting drug-
associated memories. It would be critical
to determine whether UV light exposure-
mediated enhancement in b-endorphin re-
cruits dopamine systems and produces
long-lasting synaptic changes in addic-
tion-related brain regions.
These novel findings provide possible
therapeutic targets for treating tanning
addiction and other psychiatric disorders.
Fell et al. (2014) suggest that sunblock
may be used to treat UV light addiction.
However, if UV light acts on canonical
drug-associated brain circuits andmecha-
nisms, then sunblock may only extinguish
Figure 1. Working Model of Endogenous Opioid Dependence Pro-
duced by Chronic UV Light Exposure
UV light increases p53 signaling in keratinocytes. Keratinocyte p53 signaling
increases the synthesis of POMC propeptide. POMC is processed to yield
b-endorphin and other biologically active peptides. Sustained increases in
plasma b-endorphin increases signaling at opioid receptors in the periphery
and/or central nervous system to produce an endogenous opioid-dependent
state. Opioid receptor signaling may alter the neural activity of midbrain
dopamine neurons in the ventral tegmental area (VTA) to produce elevations of
dopamine in reward-related regions, including the nucleus accumbens (NAcc)
or the prefrontal cortex (PFC). This endogenous opioid-dependent state may
underlie the addictive properties of UV bed or sun tanning and may potentially
be utilized to treat psychiatric disorders.UV-seeking behavior, but UV
light-related reward memories
may persist. These memories
may be reactivated by envi-
ronmental triggers such as
tanning-associated cues,
stress, and/or UV sunlight it-
self. Once neural adaptations
mediating addiction are in
place, it is not likely that
blocking perceived effects of
UV light would revert the ad-
dicted brain state. UV light in-
creases p53 in keratinocytes,
which stimulates the produc-
tion of proopiomelanocortin
(POMC). POMC is processed
to various peptides, including
melanogenic peptides and
b-endorphin in a tissue-spe-
cific manner. Plasma or kera-
tinocyte b-endorphin levels
may potentially be used as a
biomarker of heightened risk
of developing UV addiction.
Therapeutics that decrease
b-endorphin, but not melano-genic peptide, production from POMC
may be useful to prevent UV light
addiction but spare skin-protecting func-
tions. Drug taking in addiction is main-
tained by a drive to seek drug reward
and avoid drug withdrawal. By raising
endogenous opioid tone, UV light may
prove a useful therapeutic to alleviate
drug withdrawal symptoms. As opioid
systems have been implicated
in relapse, it would also be important to
determine whether UV light could
influence relapse in opioid abuse. UV light
exposure therapy may also prove useful
to treat conditions associated with
dysphoria or anhedonia, such as depres-
sion or seasonal affective disorder (SAD).
Indeed, depression symptoms worsen
during seasons with low sunlight, andlight exposure ameliorates these symp-
toms (Golden et al., 2005).
UV light dependence may be differ-
entially manifested depending on
developmental and evolutionary factors.
Developmentally, it is well accepted that
adolescents display increased drug-
seeking and risky behavior. Consistent
with this, there isan inverse relationshipbe-
tween age and tanning addiction (Nolan
andFeldman, 2009).With regards to evolu-
tion, mice are nocturnal and avoid high
levels of ambient light. If mice typically
avoid light, then underwhat circumstances
would they receive enough UV light expo-
sure tobecomedependentonendogenous
b-endorphin? Unlike rodents, human and
nonhumanprimates aremore active during
the daytime. It is possible that, in speciesCell 157, June 19,active during the day, light-
evoked rises in b-endorphin
alter the perceived value and
motivation to obtain reward,
which may compound UV
light reward. UV light-seeking
behavior, though evolutionarily
conserved, may differ across
development and species.
In conclusion, Fell et al.
(2014) bring forth exciting
research that will open up
newresearch thatwill elucidate
(1) our understanding of basic
physiological processes that
control motivated behavior, (2)
underlying mechanisms that
mediate sun tanning addiction,
and (3) potential new modal-
ities that can be aimed at treat-
ing psychiatric disorders.REFERENCES
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